Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.34 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23376505 | 0.94 | HSP90AA1 (0.34) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 | |
| SCHEMBL23376502 | 0.93 | HSP90AA1 (0.32) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 | |
| SCHEMBL27018046 | 0.93 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 | |
| SCHEMBL17690123 | 0.91 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 | |
| SCHEMBL27017993 | 0.91 | HCRTR1 (0.31) | — | |
| SCHEMBL24856373 | 0.91 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 | |
| SCHEMBL27017437 | 0.91 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 | |
| SCHEMBL27017983 | 0.91 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 | |
| SCHEMBL23376488 | 0.90 | HSP90AA1 (0.33) | HSP90AA1HSP90AB1ALOX5 | |
| SCHEMBL23376511 | 0.90 | HSP90AA1 (0.33) | PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240023428-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20240023428-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023428-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | L1CAM, EPCAM, SELE | PLA2G2A 2381/4885PLA2G4A 3202/4885PLA2G10 2666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.